Outcomes of patients hospitalized for acute decompensated heart failure: does nesiritide make a difference?

[1]  R. J. Carroll,et al.  Mortality associated with nesiritide: Letter to the Editor , 2007 .

[2]  R. J. Carroll,et al.  Mortality associated with nesiritide. , 2007, American heart journal.

[3]  K. Aaronson,et al.  Risk of death associated with nesiritide in patients with acutely decompensated heart failure. , 2006, JAMA.

[4]  PaulA. April.  Nesiritide--not verified. , 2005, The New England journal of medicine.

[5]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[6]  Z. Mulla,et al.  Nesiritide increases the odds of mortality among patients hospitalized for congestive heart failure , 2005 .

[7]  K. Adams,et al.  In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). , 2005, Journal of the American College of Cardiology.

[8]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[9]  K. Aaronson,et al.  Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. , 2005, JAMA.

[10]  K. Aaronson,et al.  Risk of Worsening Renal Function With Nesiritide in Patients With Acutely Decompensated Heart Failure , 2005, Circulation.

[11]  K. Dickstein,et al.  [Executive summary of the guidelines on the diagnosis and treatment of acute heart failure]. , 2005, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[12]  Eliot Corday,et al.  Overview of Acutely Decompensated Congestive Heart Failure (ADHF): A Report from the ADHERE Registry , 2005, Heart Failure Reviews.

[13]  Z. Mulla,et al.  Clinical pathway care improves outcomes among patients hospitalized for community-acquired pneumonia. , 2004, Annals of epidemiology.

[14]  K. Chatterjee,et al.  Effects of Intravenous Nesiritide on Human Coronary Vasomotor Regulation and Myocardial Oxygen Uptake , 2003, Circulation.

[15]  James B. Young.  Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial , 2002 .

[16]  D. Battleman,et al.  Rapid antibiotic delivery and appropriate antibiotic selection reduce length of hospital stay of patients with community-acquired pneumonia: link between quality of care and resource utilization. , 2002, Archives of internal medicine.

[17]  Stephen R. Cole,et al.  Analysis of complex survey data using SAS , 2001, Comput. Methods Programs Biomed..

[18]  M. Rich,et al.  CONGESTIVE HEART FAILURE IN OLDER ADULTS * : Epidemiology, Pathophysiology, and Etiology of Congestive Heart Failure in Older Adults , 1997, Journal of the American Geriatrics Society.

[19]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.

[20]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .